Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027300
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2001-11-30
Brief Title:
Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Sponsor:
Biogen
Organization:
Biogen
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Sclerosis Relapsing-Remitting |
Keywords:
| Name | View |
|---|---|
| Relapsing Remitting Multiple Sclerosis | View |